Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Robert Wayne Yeh, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
1997 - 1999
British Marshall Scholarship
2000
Paul and Daisy Soros Fellowship for New Americans
2011
Thomas J. Linnemeier Young Investigator Award, Transcatheter Cardiovascular Therapeutics (TCT)
2015
Young Physician-Scientist Award, American Society for Clinical Investigation (ASCI)
2018
Young Mentor Award

Overview
Dr. Robert W. Yeh is the Director of the Richard and Susan Smith Center for Outcomes Research in Cardiology at the Beth Israel Deaconess Medical Center, and Associate Professor of Medicine at Harvard Medical School. His area of investigation focuses on evaluating cardiovascular devices and therapies in both clinical trials and observational studies, with an emphasis on understanding methods to improve the value of novel technologies as they are used in clinical practice. He serves as the Medical Director of Trial Design for the Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute).

Clinically, Dr. Yeh is the Associate Chief of Interventional Cardiology and the Director of Complex Coronary Intervention at BIDMC.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HL139837 (MORAN, ANDREW EDWARD) Dec 15, 2017 - Nov 30, 2021
    NIH
    Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT (Optimize-SPRINT)
    Role: Co-Investigator
  2. R01HL136708 (YEH, ROBERT) May 1, 2017 - Mar 31, 2022
    NIH/NHLBI
    Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials
    Role: Principal Investigator
  3. K23HL118138 (YEH, ROBERT) Sep 1, 2013 - Apr 30, 2018
    NIH/NHLBI
    Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio
    Role: Principal Investigator

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Wadhera RK, Joynt Maddox KE, Yeh RW, Bhatt DL. Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo. JAMA Cardiol. 2018 Jul 01; 3(7):635-640. PMID: 29800962.
    View in: PubMed
  2. Blumenthal DM, Valsdottir LR, Zhao Y, Shen C, Kirtane AJ, Pinto DS, Resnic FS, Maddox KEJ, Wasfy JH, Mehran R, Rosenfield K, Yeh RW. A Survey of Interventional Cardiologists' Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention. JAMA Cardiol. 2018 Jul 01; 3(7):629-634. PMID: 29801157.
    View in: PubMed
  3. Secemsky EA, Shen C, Yeh RW. Exposure Misclassification in Observational Studies: Setting New Standards. Circ Cardiovasc Qual Outcomes. 2018 Jul; 11(7):e004939. PMID: 29991648.
    View in: PubMed
  4. Secemsky EA, Yeh RW. Re. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction with Cardiogenic Shock. Epidemiology. 2018 Jun 27. PMID: 29958193.
    View in: PubMed
  5. Secemsky EA, Rosenfield K, Kennedy KF, Jaff M, Yeh RW. High Burden of 30-Day Readmissions After Acute Venous Thromboembolism in the United States. J Am Heart Assoc. 2018 Jun 26; 7(13). PMID: 29945913.
    View in: PubMed
  6. Wadhera RK, Shen C, Secemsky EA, Strom JB, Yeh RW. State Variation in the Use of Non-Acute Coronary Angiograms and Coronary Revascularization Procedures. JACC Cardiovasc Interv. 2018 May 14; 11(9):912-913. PMID: 29747922.
    View in: PubMed
  7. Tamez H, Généreux P, Yeh RW, Amin AP, Fan W, White HD, Kirtane AJ, Stone GW, Gibson CM, Harrington RA, Bhatt DL, Pinto DS. Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study. Catheter Cardiovasc Interv. 2018 May 04. PMID: 29726596.
    View in: PubMed
  8. Secemsky EA, Yeh RW. Complete vs Incomplete Revascularization During Percutaneous Coronary Intervention and Improved Survival-The Key Is Immortality. JAMA Cardiol. 2018 May 01; 3(5):443-444. PMID: 29590282.
    View in: PubMed
  9. Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES. The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry. JACC Cardiovasc Interv. 2018 Jul 23; 11(14):1325-1335. PMID: 29706508.
    View in: PubMed
  10. Wadhera RK, Joynt Maddox KE, Wang Y, Shen C, Yeh RW. 30-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries. JACC Heart Fail. 2018 May; 6(5):379-387. PMID: 29655827.
    View in: PubMed
  11. Strom JB, Zhao Y, Shen C, Chung M, Pinto DS, Popma JJ, Yeh RW. National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock. EuroIntervention. 2018 Apr 06; 13(18):e2152-e2159. PMID: 29400657.
    View in: PubMed
  12. Yeh RW. Academic Cardiology and Social Media: Navigating the Wisdom and Madness of the Crowd. Circ Cardiovasc Qual Outcomes. 2018 Apr; 11(4):e004736. PMID: 29650720.
    View in: PubMed
  13. Butala NM, Kramer DB, Shen C, Strom JB, Kennedy KF, Wang Y, Valsdottir LR, Wasfy JH, Yeh RW. Applicability of Publicly Reported Hospital Readmission Measures to Unreported Conditions and Other Patient Populations: A Cross-sectional All-Payer Study. Ann Intern Med. 2018 May 01; 168(9):631-639. PMID: 29582086.
    View in: PubMed
  14. Jena AB, Olenski A, Blumenthal DM, Yeh RW, Goldman DP, Romley J. Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings. J Am Heart Assoc. 2018 Mar 09; 7(6). PMID: 29523525.
    View in: PubMed
  15. Danek BA, Basir MB, O'Neill WW, Alqarqaz M, Karatasakis A, Karmpaliotis D, Jaffer FA, Yeh RW, Wyman M, Lombardi WL, Kandzari D, Lembo N, Doing A, Patel M, Mahmud E, Choi JW, Toma C, Moses JW, Kirtane A, Parikh M, Ali ZA, Garcia S, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES, Alaswad K. Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry. J Invasive Cardiol. 2018 03; 30(3):81-87. PMID: 29493509.
    View in: PubMed
  16. Wadhera RK, Joynt Maddox KE, Wang Y, Shen C, Bhatt DL, Yeh RW. Association Between 30-Day Episode Payments and Acute Myocardial Infarction Outcomes Among Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2018 Mar; 11(3):e004397. PMID: 29530887.
    View in: PubMed
  17. Faridi KF, Popma JJ, Strom JB, Shen C, Choi E, Yeh RW. Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval. Am J Cardiol. 2018 Jun 01; 121(11):1365-1372. PMID: 29627105.
    View in: PubMed
  18. Faridi KF, Yeh RW. Risk score identifies patients who will benefit from prolonged dual antiplatelet therapy. BMJ Evid Based Med. 2018 Apr; 23(2):73-74. PMID: 29595135.
    View in: PubMed
  19. Yang JX, Yeh RW. Safety and effectiveness of zotarolimus-eluting stents for percutaneous coronary intervention: a systematic review. Future Cardiol. 2018 May 01; 14(3):251-267. PMID: 29448810.
    View in: PubMed
  20. Vidula MK, Secemsky EA, Yeh RW. Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician. Prog Cardiovasc Dis. 2018 Jan - Feb; 60(4-5):491-499. PMID: 29409813.
    View in: PubMed
  21. Wasfy JH, Yeh RW. Understanding How to Improve Quality and Value for Patients With Acute Myocardial Infarction. JAMA Cardiol. 2018 Feb 01; 3(2):102-103. PMID: 29261834.
    View in: PubMed
  22. Ko SQ, Strom JB, Shen C, Yeh RW. Mortality, Length of Stay, and Cost of Weekend Admissions. J Hosp Med. 2018 07 01; 13(7):476-481. PMID: 29370319.
    View in: PubMed
  23. Wadhera RK, Yeh RW, Joynt Maddox KE. The Rise and Fall of Mandatory Cardiac Bundled Payments. JAMA. 2018 01 23; 319(4):335-336. PMID: 29327034.
    View in: PubMed
  24. Elmariah S, Doros G, Benavente OR, Bhatt DL, Connolly SJ, Yusuf S, Steinhubl SR, Liu Y, Hsieh WH, Yeh RW, Mauri L. Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis. Circ Cardiovasc Interv. 2018 Jan; 11(1):e005795. PMID: 29311290.
    View in: PubMed
  25. Weintraub WS, Yeh RW. Challenges of Assessing Therapeutic or Diagnostic Outcomes with Observational Data. Am J Med. 2018 Feb; 131(2):206-210. PMID: 29103925.
    View in: PubMed
  26. Secemsky EA, Schermerhorn M, Carroll BJ, Kennedy KF, Shen C, Valsdottir LR, Landon B, Yeh RW. Readmissions After Revascularization Procedures for Peripheral Arterial Disease: A Nationwide Cohort Study. Ann Intern Med. 2018 Jan 16; 168(2):93-99. PMID: 29204656.
    View in: PubMed
  27. Strom JB, Yeh RW. Should We Care About Short-Term Readmissions After Percutaneous Coronary Intervention? Circ Cardiovasc Interv. 2017 Dec; 10(12). PMID: 29246919.
    View in: PubMed
  28. Wadhera RK, Anderson JD, Yeh RW. High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications. Curr Heart Fail Rep. 2017 12; 14(6):514-518. PMID: 29101664.
    View in: PubMed
  29. Blumenthal DM, Mikhael B, Lawler PR, Yeh RW, Metlay JP, Dudzinski DM. Personal and Professional Characteristics of U.S. Dual-Boarded Critical Care Cardiologists in 2015. Crit Care Med. 2017 Dec; 45(12):e1292-e1296. PMID: 29023259.
    View in: PubMed
  30. Secemsky EA, Yeh RW. Brachial-ankle pulse wave velocity as a marker of adverse events following non-ST-elevation myocardial infarction: a new standard in risk stratification? Coron Artery Dis. 2017 12; 28(8):634-635. PMID: 28825931.
    View in: PubMed
  31. Tajti P, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Toma C, Uretsky B, Garcia S, Moses JW, Parikh M, Kirtane A, Ali ZA, Hatem R, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES. Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry. J Invasive Cardiol. 2018 03; 30(3):89-96. PMID: 29138364.
    View in: PubMed
  32. Valle JA, Kaltenbach LA, Bradley SM, Yeh RW, Rao SV, Gurm HS, Armstrong EJ, Messenger JC, Waldo SW. Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry. JACC Cardiovasc Interv. 2017 Nov 27; 10(22):2242-2254. PMID: 29102582.
    View in: PubMed
  33. Yeh RW, Kereiakes DJ, Steg PG, Cutlip DE, Croce KJ, Massaro JM, Mauri L. Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2017 Oct 31; 70(18):2213-2223. PMID: 29073947.
    View in: PubMed
  34. Hess GP, Natarajan P, Faridi KF, Fievitz A, Valsdottir L, Yeh RW. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing. Circulation. 2017 Dec 05; 136(23):2210-2219. PMID: 29084735.
    View in: PubMed
  35. Patel SM, Menon RV, Burke MN, Jaffer FA, Yeh RW, Vo M, Karmpaliotis D, Azzalini L, Carlino M, Mashayekhi K, Galassi AR, Rinfret S, Ellis SG, Patel M, Rangan BV, Karatasakis A, Danek BA, Karacsonyi J, Resendes E, Banerjee S, Brilakis ES. Current Perspectives and Practices on Chronic Total Occlusion Percutaneous Coronary Interventions. J Invasive Cardiol. 2018 02; 30(2):43-50. PMID: 29035846.
    View in: PubMed
  36. Yeh RW, Kirtane AJ, Rao SV. Incentivizing Transradial Access for Primary Percutaneous Coronary Intervention While Maintaining Timely Reperfusion. JAMA Cardiol. 2017 Oct 01; 2(10):1057-1058. PMID: 28813548.
    View in: PubMed
  37. Hess PL, Kennedy K, Cowherd M, Virani SS, Masoudi FA, Navar AM, Yeh RW, Ho PM, Maddox TM. Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project. Am Heart J. 2018 Jan; 195:151-152. PMID: 29224643.
    View in: PubMed
  38. Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Patel D, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States. Circ Cardiovasc Qual Outcomes. 2017 Sep; 10(9). PMID: 28855222.
    View in: PubMed
  39. Grodzinsky A, Kosiborod M, Tang F, Jones PG, McGuire DK, Spertus JA, Beltrame JF, Jang JS, Goyal A, Butala NM, Yeh RW, Arnold SV. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus. Circ Cardiovasc Qual Outcomes. 2017 Sep; 10(9). PMID: 28904076.
    View in: PubMed
  40. Feldman DN, Yeh RW. Public Reporting of Percutaneous Coronary Intervention Mortality in New York State: Are We Helping Our Patients? Circ Cardiovasc Qual Outcomes. 2017 Sep; 10(9). PMID: 28893834.
    View in: PubMed
  41. Butala NM, Secemsky EA, Wasfy JH, Kennedy KF, Yeh RW. Seasonality and Readmission after Heart Failure, Myocardial Infarction, and Pneumonia. Health Serv Res. 2017 Aug 31. PMID: 28857149.
    View in: PubMed
  42. Secemsky EA, Gallagher R, Harkness J, Pomerantsev E, Gewirtz H, Jaffer FA, Yeh RW. Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions. J Am Coll Cardiol. 2017 Aug 29; 70(9):1196-1197. PMID: 28838371.
    View in: PubMed
  43. Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W, McCabe JM, Karmpaliotis D, Moses J, Nicholson WJ, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Thompson CR, Marso SP, Nugent K, Gosch K, Spertus JA, Grantham JA. Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC Cardiovasc Interv. 2017 Aug 14; 10(15):1523-1534. PMID: 28797429.
    View in: PubMed
  44. Tahir UA, Yeh RW. Individualizing dual antiplatelet therapy duration after percutaneous coronary intervention: from randomized control trials to personalized medicine. Expert Rev Cardiovasc Ther. 2017 Sep; 15(9):681-693. PMID: 28764572.
    View in: PubMed
  45. Kramer DB, Yeh RW. Practical Improvements for Medical Device Evaluation. JAMA. 2017 07 25; 318(4):332-334. PMID: 28742887.
    View in: PubMed
  46. Secemsky EA, Yeh RW, Mauri L. Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug. JACC Cardiovasc Interv. 2017 Jul 24; 10(14):1468-1469. PMID: 28728663.
    View in: PubMed
  47. Danek BA, Karatasakis A, Tajti P, Sandoval Y, Karmpaliotis D, Alaswad K, Jaffer F, Yeh RW, Kandzari DE, Lembo NJ, Patel MP, Mahmud E, Choi JW, Doing AH, Lombardi WL, Wyman RM, Toma C, Garcia S, Moses JW, Kirtane AJ, Hatem R, Ali ZA, Parikh M, Karacsonyi J, Rangan BV, Khalili H, Burke MN, Banerjee S, Brilakis ES. Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2017 Oct 15; 120(8):1285-1292. PMID: 28826896.
    View in: PubMed
  48. O'Brien C, Valsdottir L, Wasfy JH, Strom JB, Secemsky EA, Wang Y, Yeh RW. Comparison of 30-Day Readmission Rates After Hospitalization for Acute Myocardial Infarction in Men Versus Women. Am J Cardiol. 2017 Oct 01; 120(7):1070-1076. PMID: 28781023.
    View in: PubMed
  49. Strom JB, Kramer DB, Wang Y, Shen C, Wasfy JH, Landon BE, Wilker EH, Yeh RW. Short-term rehospitalization across the spectrum of age and insurance types in the United States. PLoS One. 2017; 12(7):e0180767. PMID: 28700736.
    View in: PubMed
  50. Tamez H, Pinto DS, Kirtane AJ, Litherland C, Yeh RW, Dangas GD, Mehran R, Deliargyris EN, Ortiz G, Gibson CM, Stone GW. Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial. JAMA Cardiol. 2017 Jun 01; 2(6):673-677. PMID: 28249084.
    View in: PubMed
  51. Jovin IS, Shah RM, Patel DB, Rao SV, Baklanov DV, Moussa I, Kennedy KF, Secemsky EA, Yeh RW, Kontos MC, Vetrovec GW. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2017 Jun 12; 10(11):1102-1111. PMID: 28527778.
    View in: PubMed
  52. Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Doing A, Toma C, Uretsky B, Choi J, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Martinez-Parachini JR, Karatasakis A, Danek BA, Alame AJ, Resendes E, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. J Invasive Cardiol. 2017 Aug; 29(8):264-270. PMID: 28570257.
    View in: PubMed
  53. Phillips CT, Tamez H, Tu TM, Yeh RW, Pinto DS. Novel Method for Exchange of Impella Circulatory Assist Catheter: The "Trojan Horse" Technique. J Invasive Cardiol. 2017 Jul; 29(7):250-252. PMID: 28570258.
    View in: PubMed
  54. Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Steg PG, Massaro JM, Apruzzese PK, Mauri L. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study. JACC Cardiovasc Interv. 2017 May 08; 10(9):942-954. PMID: 28473118.
    View in: PubMed
  55. Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Cohen DJ, Steg PG, Cannon CP, Apruzzese PK, D'Agostino RB, Massaro JM, Mauri L. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. JAMA Cardiol. 2017 May 01; 2(5):478-487. PMID: 28297015.
    View in: PubMed
  56. Partida RA, Yeh RW. Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy. Cardiol Clin. 2017 May; 35(2):281-296. PMID: 28411902.
    View in: PubMed
  57. Strom JB, McCabe JM, Waldo SW, Pinto DS, Kennedy KF, Feldman DN, Yeh RW. Management of Patients With Cardiac Arrest Complicating Myocardial Infarction in New York Before and After Public Reporting Policy Changes. Circ Cardiovasc Interv. 2017 May; 10(5). PMID: 28495895.
    View in: PubMed
  58. Nathan AS, Sen S, Yeh RW. The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease. Expert Opin Drug Saf. 2017 May; 16(5):561-572. PMID: 28387542.
    View in: PubMed
  59. Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Lombardi W, Wyman MR, Doing A, Moses JW, Kirtane A, Parikh M, Ali Z, Kandzari D, Lembo N, Garcia S, Danek BA, Karatasakis A, Resendes E, Kalsaria P, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions. Am J Cardiol. 2017 Jul 01; 120(1):40-46. PMID: 28499595.
    View in: PubMed
  60. Giri J, Yeh RW. The Effect of Survivor Bias on Observational Analyses of Staged PCI in STEMI Patients. JACC Cardiovasc Interv. 2017 Mar 27; 10(6):629-630. PMID: 28335905.
    View in: PubMed
  61. Young MN, Elmariah S, Kennedy KF, Inglessis I, Yeh RW. Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval. Catheter Cardiovasc Interv. 2017 Nov 01; 90(5):830-838. PMID: 28326675.
    View in: PubMed
  62. Yeh RW, Kramer DB. Decision Tools to Improve Personalized Care in Cardiovascular Disease: Moving the Art of Medicine Toward Science. Circulation. 2017 Mar 21; 135(12):1097-1100. PMID: 28320801.
    View in: PubMed
  63. Kalra A, Rehman H, Khera S, Thyagarajan B, Bhatt DL, Kleiman NS, Yeh RW. New-Generation Coronary Stents: Current Data and Future Directions. Curr Atheroscler Rep. 2017 Mar; 19(3):14. PMID: 28220461.
    View in: PubMed
  64. Waldo SW, McCabe JM, Kennedy KF, Zigler CM, Pinto DS, Yeh RW. Quality of Care at Hospitals Identified as Outliers in Publicly Reported Mortality Statistics for Percutaneous Coronary Intervention. Circulation. 2017 May 16; 135(20):1897-1907. PMID: 28249879.
    View in: PubMed
  65. Stefanescu Schmidt AC, Kereiakes DJ, Cutlip DE, Yeh RW, D'Agostino RB, Massaro JM, Hsieh WH, Mauri L. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy). Circulation. 2017 May 02; 135(18):1720-1732. PMID: 28228427.
    View in: PubMed
  66. Bobb JF, Ho KK, Yeh RW, Harrington L, Zai A, Liao KP, Dominici F. Time-Course of Cause-Specific Hospital Admissions During Snowstorms: An Analysis of Electronic Medical Records From Major Hospitals in Boston, Massachusetts. Am J Epidemiol. 2017 Feb 15; 185(4):283-294. PMID: 28137774.
    View in: PubMed
  67. Blumenthal DM, Olenski AR, Yeh RW, DeFaria Yeh D, Sarma A, Stefanescu Schmidt AC, Wood MJ, Jena AB. Sex Differences in Faculty Rank Among Academic Cardiologists in the United States. Circulation. 2017 Feb 07; 135(6):506-517. PMID: 28153987.
    View in: PubMed
  68. Yeh RW, Silber S, Chen L, Chen S, Hiremath S, Neumann FJ, Qiao S, Saito S, Xu B, Yang Y, Mauri L. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program. JACC Cardiovasc Interv. 2017 Feb 13; 10(3):247-254. PMID: 28109872.
    View in: PubMed
  69. Karatasakis A, Iwnetu R, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Kandzari DE, Lembo NJ, Patel M, Mahmud E, Lombardi WL, Wyman RM, Grantham JA, Doing AH, Toma C, Choi JW, Uretsky BF, Moses JW, Kirtane AJ, Ali ZA, Parikh M, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2017 Apr; 29(4):116-122. PMID: 28089997.
    View in: PubMed
  70. Wasfy JH, Zigler CM, Choirat C, Wang Y, Dominici F, Yeh RW. Readmission Rates After Passage of the Hospital Readmissions Reduction Program: A Pre-Post Analysis. Ann Intern Med. 2017 Mar 07; 166(5):324-331. PMID: 28024302.
    View in: PubMed
  71. Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel MP, Bahadorani JN, Lombardi WL, Wyman RM, Grantham JA, Kandzari DE, Lembo NJ, Doing AH, Toma C, Moses JW, Kirtane AJ, Ali Z, Parikh M, Garcia S, Danek BA, Karacsonyi J, Alame A, Kalsaria P, Thompson C, Banerjee S, Brilakis ES. Approaches to percutaneous coronary intervention of right coronary artery chronic total occlusions: insights from a multicentre US registry. EuroIntervention. 2016 Dec 10; 12(11):e1326-e1335. PMID: 27934609.
    View in: PubMed
  72. Chatterjee S, Weinberg I, Yeh RW, Chakraborty A, Sardar P, Weinberg MD, Kabrhel C, Barnes GD, Mukherjee D, Kumbhani D, Bashir R, Vaidya A, Smith A, Fuchs B, Groeneveld P, Giri J. Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score. Thromb Haemost. 2017 01 26; 117(2):246-251. PMID: 27882375.
    View in: PubMed
  73. Christakopoulos GE, Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman MR, Lombardi WL, Tarar MN, Grantham JA, Kandzari DE, Lembo N, Moses JW, Kirtane AJ, Parikh M, Green P, Finn M, Garcia S, Doing AH, Hatem R, Thompson CA, Banerjee S, Brilakis ES. Predictors of Excess Patient Radiation Exposure During Chronic Total Occlusion Coronary Intervention: Insights From a Contemporary Multicentre Registry. Can J Cardiol. 2017 04; 33(4):478-484. PMID: 28169091.
    View in: PubMed
  74. Klein LW, Harjai KJ, Resnic F, Weintraub WS, Vernon Anderson H, Yeh RW, Feldman DN, Gigliotti OS, Rosenfeld K, Duffy P. 2016 Revision of the SCAI position statement on public reporting. Catheter Cardiovasc Interv. 2017 Feb 01; 89(2):269-279. PMID: 27755653.
    View in: PubMed
  75. Garcia S, Alraies MC, Karatasakis A, Yannopoulos D, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel MP, Bahadorani J, Karacsonyi J, Kalsaria P, Danek B, Banerjee S, Brilakis ES. Coronary artery spatial distribution of chronic total occlusions: Insights from a large US registry. Catheter Cardiovasc Interv. 2017 Jul; 90(1):23-30. PMID: 27860111.
    View in: PubMed
  76. Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Shah RM, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States. JACC Cardiovasc Interv. 2016 Dec 12; 9(23):2376-2386. PMID: 27838271.
    View in: PubMed
  77. Martinez-Parachini JR, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani J, Doing A, Nguyen-Trong PK, Danek BA, Karacsonyi J, Alame A, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. Impact of diabetes mellitus on acute outcomes of percutaneous coronary intervention in chronic total occlusions: insights from a US multicentre registry. Diabet Med. 2017 04; 34(4):558-562. PMID: 27743404.
    View in: PubMed
  78. Sapontis J, Spertus J, Yeh R, Cohen D, Lombardi W, Karmpaliotis D, Moses J, Nicholson W, Pershad A, Wyman RM, Spaedy T, Cook S, Doshi P, Federici R, Thompson C, Nugent K, Gosch K, Marso S, Grantham JA. TCT-303 Redefining Success in Hybrid Chronic Total Occlusion Angioplasty. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B124-B125. PMID: 27969646.
    View in: PubMed
  79. Riley R, Sapontis J, Jones P, Kirtane A, Yeh R, Karmpaliotis D, Grantham JA, Lombardi W, Brilakis E, McCabe J. TCT-282 Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CTO Study. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B116. PMID: 27969624.
    View in: PubMed
  80. Alame A, Karmpaliotis D, Alaswad K, Jaffer F, Yeh R, Wyman RM, Patel M, Bahadorani J, Lombardi W, Grantham JA, Kandzari D, Lembo N, Moses J, Kirtane A, Toma C, Doing A, Choi J, Uretsky B, Karacsonyi J, Resendes E, Nguyen-Trong PK, Martinez-Parachini JR, Karatasakis A, Danek BA, Rangan B, Thompson C, Banerjee S, Brilakis E. TCT-301 Outcomes of Percutaneous Coronary Intervention in Chronic Total Occlusions Caused by In-Stent Restenosis: Insights from a U.S. Multicenter Registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B123-B124. PMID: 27969644.
    View in: PubMed
  81. Karatasakis A, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh R, Kandzari D, Lembo N, Patel M, Bahadorani J, Lombardi W, Wyman RM, Grantham JA, Doing A, Toma C, Choi J, Uretsky B, Garcia S, Moses J, Kirtane A, Ali Z, Parikh M, Karacsonyi J, Rangan B, Thompson C, Banerjee S, Brilakis E. TCT-278 Application and Outcomes of the Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: an Update from a Contemporary Multicenter US Registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B113-B114. PMID: 27969620.
    View in: PubMed
  82. Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh R, Jaffer F, Patel M, Bahadorani J, Lombardi W, Wyman RM, Grantham JA, Doing A, Kandzari D, Lembo N, Garcia S, Toma C, Moses J, Kirtane A, Parikh M, Ali Z, Karacsonyi J, Alame A, Nguyen-Trong PK, Martinez-Parachini JR, Kalsaria P, Rangan B, Thompson C, Banerjee S, Brilakis E. TCT-15 Use of Antegrade Dissection Re-entry in Coronary Chronic Total Occlusion Percutaneous Coronary Intervention in a Contemporary Multicenter Registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B6-B7. PMID: 27970311.
    View in: PubMed
  83. Alraies MC, Yannopoulos D, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh R, Patel M, Bahadorani J, Karacsonyi J, Alame A, Banerjee S, Brilakis E, Garcia S. TCT-286 Coronary Artery Spatial Distribution of Chronic Total Occlusions: Insights from a large US Registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B117-B118. PMID: 27969627.
    View in: PubMed
  84. Gallagher R, Harkness J, Pomerantsev E, Jaffer F, Yeh R. TCT-294 Discordance Between Territory of Ischemia and Target Vessel in Patients with Chronic Total Occlusions. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B121. PMID: 27969639.
    View in: PubMed
  85. Patel S, Menon R, Burke MN, Jaffer FA, Yeh R, Vo M, Karmpaliotis D, Azzalini L, Carlino M, Mashayekhi K, Galassi A, Rinfret S, Ellis S, Patel M, Rangan B, Karatasakis A, Danek BA, Karacsonyi J, Resendes E, Banerjee S, Brilakis E. TCT-287 Current Perspectives and Practices on Chronic Total Occlusion Percutaneous Coronary Interventions. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B118. PMID: 27969630.
    View in: PubMed
  86. Toma C, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh R, Jaffer F, Kandzari D, Lembo N, Lombardi W, Grantham JA, Wyman RM, Doing A, Patel M, Bahadorani J, Moses J, Kirtane A, Ali Z, Danek BA, Karacsonyi J, Rangan B, Banerjee S, Brilakis E. TCT-273 Predictors of successful Stingray-assisted antegrade dissection reentry: data from the Progress CTO registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B111-B112. PMID: 27969614.
    View in: PubMed
  87. Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh R, Jaffer F, Patel M, Bahadorani J, Lombardi W, Wyman RM, Grantham JA, Doing A, Kandzari D, Lembo N, Garcia S, Toma C, Moses J, Kirtane A, Parikh M, Ali Z, Karacsonyi J, Alame A, Nguyen-Trong PK, Martinez-Parachini JR, Kalsaria P, Rangan B, Thompson C, Banerjee S, Brilakis E. TCT-281 Development and Validation of a Scoring System for Predicting Major Adverse Cardiovascular Events during Percutaneous Coronary Interventions of Chronic Total Occlusions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) MACE Score. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B115-B116. PMID: 27969623.
    View in: PubMed
  88. Resendes E, Karmpaliotis D, Alaswad K, Jaffer F, Yeh R, Wyman RM, Patel M, Bahadorani J, Lombardi W, Grantham JA, Kandzari D, Lembo N, Moses J, Kirtane A, Toma C, Doing A, Choi J, Uretsky B, Alame A, Karacsonyi J, Danek BA, Smith M, Karatasakis A, Rangan B, Banerjee S, Brilakis E. TCT-308 Impact of Race and Ethnicity on Technical and In-Hospital Outcomes Following Chronic Total Occlusions Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B126-B127. PMID: 27969651.
    View in: PubMed
  89. Karacsonyi J, Alaswad K, Jaffer F, Yeh R, Patel M, Bahadorani J, Danek BA, Karatasakis A, Doing A, Grantham JA, Karmpaliotis D, Moses J, Kirtane A, Parikh M, Ali Z, Lombardi W, Kandzari D, Lembo N, Garcia S, Wyman RM, Alame A, Martinez-Parachini JR, Nguyen-Trong PK, Resendes E, Kalsaria P, Rangan B, Ungi I, Thompson C, Banerjee S, Brilakis E. TCT-572 Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from a Contemporary Multicenter Registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B231. PMID: 27969943.
    View in: PubMed
  90. Jaffer F, Grantham JA, Sapontis J, Spertus J, Gosch K, Jones P, Bruckel J, Lombardi W, Yeh R. TCT-284 Interrelationship between depression, angina, and dyspnea before and after CTO PCI in the OPEN CTO Registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B116-B117. PMID: 27969626.
    View in: PubMed
  91. Karatasakis A, Danek BA, Karmpaliotis D, Alaswad K, Jaffer F, Yeh R, Patel M, Bahadorani J, Lombardi W, Wyman RM, Grantham JA, Kandzari D, Lembo N, Doing A, Toma C, Moses J, Kirtane A, Parikh M, Ali Z, Garcia S, Kalsaria P, Karacsonyi J, Alame A, Thompson C, Banerjee S, Brilakis E. TCT-289 Comparison of Various Scores for Predicting Success and Efficiency of Chronic Total Occlusion Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B119. PMID: 27969631.
    View in: PubMed
  92. Gupta A, Yeh RW, Tamis-Holland JE, Patel SH, Guyton RA, Klein LW, Rab T, Kirtane AJ. Implications of Public Reporting of Risk-Adjusted Mortality Following Percutaneous Coronary Intervention: Misperceptions and Potential Consequences for High-Risk Patients Including Nonsurgical Patients. JACC Cardiovasc Interv. 2016 Oct 24; 9(20):2077-2085. PMID: 27765301.
    View in: PubMed
  93. Secemsky EA, Butala NM, Kartoun U, Mahmood S, Wasfy JH, Kennedy KF, Shaw SY, Yeh RW. Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2016 10 17; 5(10). PMID: 27792650.
    View in: PubMed
  94. Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Patel MP, Mahmud E, Lombardi WL, Wyman MR, Grantham JA, Doing A, Kandzari DE, Lembo NJ, Garcia S, Toma C, Moses JW, Kirtane AJ, Parikh MA, Ali ZA, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. Development and Validation of a Scoring System for Predicting Periprocedural Complications During Percutaneous Coronary Interventions of Chronic Total Occlusions: The Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS CTO) Complications Score. J Am Heart Assoc. 2016 10 11; 5(10). PMID: 27729332.
    View in: PubMed
  95. Karatasakis A, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel MP, Bahadorani JN, Wyman RM, Lombardi WL, Grantham JA, Kandzari DE, Lembo NJ, Doing AH, Moses JW, Kirtane AJ, Garcia S, Parikh MA, Ali ZA, Karacsonyi J, Kalra S, Rangan BV, Kalsaria P, Thompson CA, Banerjee S, Brilakis ES. Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry. J Invasive Cardiol. 2016 Oct; 28(10):391-396. PMID: 27705889.
    View in: PubMed
  96. Tahir U, Yeh RW. Duration of dual antiplatelet therapy (DAPT): a call for personalized medicine. J Thorac Dis. 2016 Oct; 8(10):E1226-E1229. PMID: 27867593.
    View in: PubMed
  97. Ghoshhajra BB, Takx RAP, Stone LL, Girard EE, Brilakis ES, Lombardi WL, Yeh RW, Jaffer FA. Real-time fusion of coronary CT angiography with x-ray fluoroscopy during chronic total occlusion PCI. Eur Radiol. 2017 Jun; 27(6):2464-2473. PMID: 27663227.
    View in: PubMed
  98. Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani J, Doing A, Ali ZA, Karatasakis A, Danek BA, Rangan BV, Alame AJ, Banerjee S, Brilakis ES. Prevalence, indications and management of balloon uncrossable chronic total occlusions: Insights from a contemporary multicenter US registry. Catheter Cardiovasc Interv. 2017 Jul; 90(1):12-20. PMID: 27650935.
    View in: PubMed
  99. Federspiel JJ, Anstrom KJ, Xian Y, McCoy LA, Effron MB, Faries DE, Zettler M, Mauri L, Yeh RW, Peterson ED, Wang TY. Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention. JAMA Cardiol. 2016 09 01; 1(6):655-65. PMID: 27438179.
    View in: PubMed
  100. McCabe JM, Waldo SW, Kennedy KF, Yeh RW. Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York. JAMA Cardiol. 2016 09 01; 1(6):648-54. PMID: 27463734.
    View in: PubMed
  101. Secemsky EA, Wimmer NJ, Yeh RW. Letter by Secemsky et al Regarding Article, "Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271?845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society". Circ Cardiovasc Interv. 2016 09; 9(9). PMID: 27630028.
    View in: PubMed
  102. Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Gabriel Steg P, Hsieh WH, Mauri L. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Circulation. 2016 Oct 04; 134(14):989-998. PMID: 27576774.
    View in: PubMed
  103. Tanguturi VK, Temin E, Yeh RW, Thompson RW, Rao SK, Mallick A, Cavallo E, Ferris TG, Wasfy JH. Clinical Interventions to Reduce Preventable Hospital Readmission After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2016 09; 9(5):600-4. PMID: 27553598.
    View in: PubMed
  104. Karatasakis A, Danek BA, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani JN, Lombardi WL, Wyman RM, Grantham JA, Kandzari DE, Lembo NJ, Doing AH, Toma C, Moses JW, Kirtane AJ, Parikh MA, Ali ZA, Garcia S, Kalsaria P, Karacsonyi J, Alame AJ, Thompson CA, Banerjee S, Brilakis ES. Comparison of various scores for predicting success of chronic total occlusion percutaneous coronary intervention. Int J Cardiol. 2016 Dec 01; 224:50-56. PMID: 27611917.
    View in: PubMed
  105. Karacsonyi J, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani J, Karatasakis A, Danek BA, Doing A, Grantham JA, Karmpaliotis D, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Alame A, Nguyen-Trong PK, Resendes E, Kalsaria P, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. J Am Heart Assoc. 2016 08 20; 5(8). PMID: 27543800.
    View in: PubMed
  106. Christakopoulos GE, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, Lombardi W, Grantham JA, Kandzari DA, Lembo N, Moses JW, Kirtane A, Parikh M, Green P, Finn M, Garcia S, Doing A, Patel M, Bahadorani J, Christopoulos G, Karatasakis A, Thompson CA, Banerjee S, Brilakis ES. Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry. J Invasive Cardiol. 2016 Jul; 28(7):288-94. PMID: 27342206.
    View in: PubMed
  107. Stefanescu Schmidt AC, DeFaria Yeh D, Tabtabai S, Kennedy KF, Yeh RW, Bhatt AB. National Trends in Hospitalizations of Adults With Tetralogy of Fallot. Am J Cardiol. 2016 09 15; 118(6):906-911. PMID: 27530825.
    View in: PubMed
  108. Chatterjee S, Yeh RW, Sardar P, Ul Hassan Virk H, Mukherjee D, Parikh SA, Kumbhani DJ, Kirtane A, Bashir R, Cohen H, Kolansky DM, Wilensky RL, Giri J. Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data. Catheter Cardiovasc Interv. 2016 Nov; 88(5):697-707. PMID: 27341605.
    View in: PubMed
  109. Partida RA, Yeh RW. Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy. Interv Cardiol Clin. 2016 07; 5(3):331-347. PMID: 28582031.
    View in: PubMed
  110. Karmpaliotis D, Karatasakis A, Alaswad K, Jaffer FA, Yeh RW, Wyman RM, Lombardi WL, Grantham JA, Kandzari DE, Lembo NJ, Doing A, Patel M, Bahadorani JN, Moses JW, Kirtane AJ, Parikh M, Ali ZA, Kalra S, Nguyen-Trong PK, Danek BA, Karacsonyi J, Rangan BV, Roesle MK, Thompson CA, Banerjee S, Brilakis ES. Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry. Circ Cardiovasc Interv. 2016 06; 9(6). PMID: 27307562.
    View in: PubMed
  111. Decker C, Garavalia L, Garavalia B, Gialde E, Yeh RW, Spertus J, Chhatriwalla AK. Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention. Am Heart J. 2016 08; 178:190-7. PMID: 27502869.
    View in: PubMed
  112. Karatasakis A, Tarar MN, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, Lombardi WL, Grantham JA, Kandzari DE, Lembo NJ, Moses JW, Kirtane AJ, Parikh M, Garcia S, Doing A, Pershad A, Shah A, Patel M, Bahadorani J, Shoultz CA, Danek BA, Thompson CA, Banerjee S, Brilakis ES. Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry. Catheter Cardiovasc Interv. 2017 Mar 01; 89(4):E90-E98. PMID: 27184465.
    View in: PubMed
  113. Waldo SW, Abtahian F, Kennedy KF, Scirica BM, Mahmood S, Yeh RW. Incidence and predictors of incomplete revascularization in a contemporary cohort. Coron Artery Dis. 2016 May; 27(3):191-8. PMID: 26882019.
    View in: PubMed
  114. Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016 Apr 26; 315(16):1735-49. PMID: 27022822.
    View in: PubMed
  115. Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel MP, Bahadorani J, Lombardi WL, Wyman RM, Grantham JA, Kandzari DE, Lembo NJ, Doing AH, Toma C, Moses JW, Kirtane AJ, Ali ZA, Parikh M, Garcia S, Nguyen-Trong PK, Karacsonyi J, Alame AJ, Kalsaria P, Thompson C, Banerjee S, Brilakis ES. Effect of Lesion Age on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary US Multicenter Registry. Can J Cardiol. 2016 12; 32(12):1433-1439. PMID: 27476986.
    View in: PubMed
  116. Danek BA, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Patel M, Bahadorani J, Lombardi WL, Wyman MR, Grantham JA, Doing A, Moses JW, Kirtane A, Parikh M, Ali ZA, Kalra S, Kandzari DE, Lembo N, Garcia S, Rangan BV, Thompson CA, Banerjee S, Brilakis ES. Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry. Int J Cardiol. 2016 Jul 01; 214:428-37. PMID: 27088405; PMCID: PMC4862911 [Available on 07/01/17].
  117. Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Steg PG, Wiviott SD, Mauri L. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. J Am Coll Cardiol. 2016 May 31; 67(21):2492-502. PMID: 27046159.
    View in: PubMed
  118. Wimmer NJ, Secemsky EA, Mauri L, Roe MT, Saha-Chaudhuri P, Dai D, McCabe JM, Resnic FS, Gurm HS, Yeh RW. Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis. Circ Cardiovasc Interv. 2016 Apr; 9(4):e003464. PMID: 27059685; PMCID: PMC4832135 [Available on 04/01/17].
  119. Meredith IT, Tanguay JF, Kereiakes DJ, Cutlip DE, Yeh RW, Garratt KN, Lee DP, Steg PG, Weaver WD, Holmes DR, Brindis RG, Trebacz J, Massaro JM, Hsieh WH, Mauri L. Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study. Circulation. 2016 May 03; 133(18):1772-82. PMID: 26994121.
    View in: PubMed
  120. Monteleone PP, Yeh RW. Management of Complications. Interv Cardiol Clin. 2016 04; 5(2):201-209. PMID: 28582204.
    View in: PubMed
  121. Wasfy JH, Dominici F, Yeh RW. Letter by Wasfy et al Regarding Article, "Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System (VA CART) Program". Circulation. 2016 Feb 02; 133(5):e376. PMID: 26831441.
    View in: PubMed
  122. Kramer DB, Yeh RW, Zimetbaum PJ. Editorial Commentary: Hard questions for mobile technology in cardiology. Trends Cardiovasc Med. 2016 May; 26(4):387-8. PMID: 26919932; PMCID: PMC4838996.
  123. Karacsonyi J, Karatasakis A, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman MR, Lombardi WL, Grantham JA, Kandzari DE, Lembo N, Moses JW, Kirtane AJ, Parikh MA, Green P, Finn M, Garcia S, Doing A, Patel M, Bahadorani J, Martinez Parachini JR, Resendes E, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry). Am J Cardiol. 2016 Apr 15; 117(8):1267-71. PMID: 26899493; PMCID: PMC4811706 [Available on 04/15/17].
  124. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):447-54. PMID: 26811276.
    View in: PubMed
  125. Wasfy JH, Yeh RW. Future of the PCI Readmission Metric. Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):186-9. PMID: 26812931.
    View in: PubMed
  126. Hermiller JB, Krucoff MW, Kereiakes DJ, Windecker S, Steg PG, Yeh RW, Cohen DJ, Cutlip DE, Massaro JM, Hsieh WH, Mauri L. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. JACC Cardiovasc Interv. 2016 Jan 25; 9(2):138-47. PMID: 26793956.
    View in: PubMed
  127. Christopoulos G, Kandzari DE, Yeh RW, Jaffer FA, Karmpaliotis D, Wyman MR, Alaswad K, Lombardi W, Grantham JA, Moses J, Christakopoulos G, Tarar MNJ, Rangan BV, Lembo N, Garcia S, Cipher D, Thompson CA, Banerjee S, Brilakis ES. Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score. JACC Cardiovasc Interv. 2016 Jan 11; 9(1):1-9. PMID: 26762904.
    View in: PubMed
  128. Keach JW, Yeh RW, Maddox TM. Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease. Curr Atheroscler Rep. 2016 Jan; 18(1):5. PMID: 26753771.
    View in: PubMed
  129. Meyersohn N, Scheske J, Gallagher R, Yeh R, Ghoshhajra B. Coronary CT angiography for myocardial infarction: case studies of the Massachusetts General Hospital. Coron Artery Dis. 2016 Jan; 27(1):72-3. PMID: 26618936.
    View in: PubMed
  130. Kadakia MB, Rao SV, McCoy L, Choudhuri PS, Sherwood MW, Lilly S, Kobayashi T, Kolansky DM, Wilensky RL, Yeh RW, Giri J. Transradial Versus Transfemoral Access in Patients Undergoing Rescue Percutaneous Coronary Intervention After Fibrinolytic Therapy. JACC Cardiovasc Interv. 2015 Dec 21; 8(14):1868-76. PMID: 26718516.
    View in: PubMed
  131. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):e38-360. PMID: 26673558.
    View in: PubMed
  132. Bruckel J, Wagle N, O'Brien C, Elias J, McKenna S, Meyers P, Fifer MA, Pomerantsev E, Yeh RW. Feasibility of a Tablet Computer System to Collect Patient-reported Symptom Severity in Patients Undergoing Diagnostic Coronary Angiography. Crit Pathw Cardiol. 2015 Dec; 14(4):139-45. PMID: 26569653.
    View in: PubMed
  133. Mauri L, Elmariah S, Yeh RW, Cutlip DE, Steg PG, Windecker S, Wiviott SD, Cohen DJ, Massaro JM, D'Agostino RB, Braunwald E, Kereiakes DJ. Causes of late mortality with dual antiplatelet therapy after coronary stents. Eur Heart J. 2016 Jan 21; 37(4):378-85. PMID: 26586780; PMCID: PMC4751218 [Available on 01/21/17].
  134. Wasfy JH, Kennedy KF, Chen JS, Ferris TG, Maddox TM, Yeh RW. Practice Variation in Triple Therapy for Patients With Both Atrial Fibrillation and Coronary Artery Disease: Insights From the ACC's National Cardiovascular Data Registry. JACC Clin Electrophysiol. 2016 Feb; 2(1):36-43. PMID: 29766851.
    View in: PubMed
  135. Yeh RW, Kereiakes DJ, Mauri L. Reply: Analysis of Dual Antiplatelet Therapy. J Am Coll Cardiol. 2015 Nov 03; 66(18):2056. PMID: 26516012.
    View in: PubMed
  136. Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L. Mortality risk with dual antiplatelet therapy? Lancet. 2015 Oct 17; 386(10003):1533-4. PMID: 26530618; PMCID: PMC4671290 [Available on 10/17/16].
  137. Wasfy JH, Hidrue MK, Yeh RW, Armstrong K, Dec GW, Pomerantsev EV, Fifer MA, Ferris TG. Differences Among Cardiologists in Rates of Positive Coronary Angiograms. J Am Heart Assoc. 2015 Oct 16; 4(10):e002393. PMID: 26475298; PMCID: PMC4845144.
  138. Bruckel JT, Jaffer FA, O'Brien C, Stone L, Pomerantsev E, Yeh RW. Angina Severity, Depression, and Response to Percutaneous Revascularization in Patients With Chronic Total Occlusion of Coronary Arteries. J Invasive Cardiol. 2016 Feb; 28(2):44-51. PMID: 26477043.
    View in: PubMed
  139. Waldo SW, Chang L, Strom JB, O'Brien C, Pomerantsev E, Yeh RW. Predicting the Presence of an Acute Coronary Lesion Among Patients Resuscitated From Cardiac Arrest. Circ Cardiovasc Interv. 2015 Oct; 8(10). PMID: 26453684.
    View in: PubMed
  140. Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. JACC Cardiovasc Interv. 2015 Oct; 8(12):1552-62. PMID: 26493248.
    View in: PubMed
  141. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Response to Letter Regarding Article, "Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention". Circulation. 2015 Sep 22; 132(12):e156. PMID: 26391303.
    View in: PubMed
  142. Yeh RW, Kereiakes DJ, Mauri L. Reply: Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities. J Am Coll Cardiol. 2015 Sep 08; 66(10):1204-5. PMID: 26338005.
    View in: PubMed
  143. Wasfy JH, Singal G, O'Brien C, Blumenthal DM, Kennedy KF, Strom JB, Spertus JA, Mauri L, Normand SL, Yeh RW. Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record. Circ Cardiovasc Qual Outcomes. 2015 Sep; 8(5):477-85. PMID: 26286871.
    View in: PubMed
  144. Chang L, Yeh RW. Assessing the optimal strategy for dual antiplatelet therapy. Expert Rev Cardiovasc Ther. 2015 Oct; 13(10):1067-9. PMID: 26224530.
    View in: PubMed
  145. Chatterjee S, Herrmann HC, Wilensky RL, Hirshfeld J, McCormick D, Frankel DS, Yeh RW, Armstrong EJ, Kumbhani DJ, Giri J. Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database. JAMA Intern Med. 2015 Jul; 175(7):1104-9. PMID: 25938303.
    View in: PubMed
  146. Christopoulos G, Wyman RM, Alaswad K, Karmpaliotis D, Lombardi W, Grantham JA, Yeh RW, Jaffer FA, Cipher DJ, Rangan BV, Christakopoulos GE, Kypreos MA, Lembo N, Kandzari D, Garcia S, Thompson CA, Banerjee S, Brilakis ES. Clinical Utility of the Japan-Chronic Total Occlusion Score in Coronary Chronic Total Occlusion Interventions: Results from a Multicenter Registry. Circ Cardiovasc Interv. 2015 Jul; 8(7):e002171. PMID: 26162857; PMCID: PMC4503382.
  147. Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, Lombardi WL, Menon RV, Grantham JA, Kandzari DE, Lembo N, Moses JW, Kirtane AJ, Parikh M, Green P, Finn M, Garcia S, Doing A, Patel M, Bahadorani J, Tarar MN, Christakopoulos GE, Thompson CA, Banerjee S, Brilakis ES. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol. 2015 Nov 01; 198:222-8. PMID: 26189193; PMCID: PMC4554818 [Available on 11/01/16].
  148. Tabtabai S, DeFaria Yeh D, Stefanescu A, Kennedy K, Yeh RW, Bhatt AB. National Trends in Hospitalizations for Patients With Single-Ventricle Anatomy. Am J Cardiol. 2015 Sep 01; 116(5):773-8. PMID: 26100589.
    View in: PubMed
  149. Matteau A, Yeh RW, Camenzind E, Steg PG, Wijns W, Mills J, Gershlick A, de Belder M, Ducrocq G, Mauri L. Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents. Am J Cardiol. 2015 Sep 01; 116(5):686-93. PMID: 26187674; PMCID: PMC4670082.
  150. Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L. Dual antiplatelet therapy duration and mortality - Authors' reply. Lancet. 2015 May 30; 385(9983):2149-50. PMID: 26068262.
    View in: PubMed
  151. Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart. 2015 Oct; 101(20):1631-8. PMID: 26025084.
    View in: PubMed
  152. McNamara RL, Spatz ES, Kelley TA, Stowell CJ, Beltrame J, Heidenreich P, Tresserras R, Jernberg T, Chua T, Morgan L, Panigrahi B, Rosas Ruiz A, Rumsfeld JS, Sadwin L, Schoeberl M, Shahian D, Weston C, Yeh R, Lewin J. Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc. 2015 May 19; 4(5). PMID: 25991011; PMCID: PMC4599409.
  153. Hawkins BM, Kennedy KF, Aronow HD, Nguyen LL, White CJ, Rosenfield K, Normand ST, Spertus JA, Yeh RW. Hospital variation in carotid stenting outcomes. JACC Cardiovasc Interv. 2015 May; 8(6):858-863. PMID: 25999111.
    View in: PubMed
  154. Wasfy JH, Borden WB, Secemsky EA, McCabe JM, Yeh RW. Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement. Circulation. 2015 Apr 28; 131(17):1518-27. PMID: 25918041.
    View in: PubMed
  155. Giri J, Parikh SA, Kennedy KF, Weinberg I, Donaldson C, Hawkins BM, McCormick DJ, Jackson B, Armstrong EJ, Ramchand P, White CJ, Jaff MR, Rosenfield K, Yeh RW. Proximal versus distal embolic protection for carotid artery stenting: a national cardiovascular data registry analysis. JACC Cardiovasc Interv. 2015 Apr 20; 8(4):609-15. PMID: 25907088.
    View in: PubMed
  156. Mandawat A, McCullough SA, Gilstrap LG, Yeh RW. Successful treatment of flecainide overdose with sustained mechanical circulatory support. HeartRhythm Case Rep. 2015 May; 1(3):137-140. PMID: 28491532.
    View in: PubMed
  157. Mauri L, Yeh RW, Kereiakes DJ. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2015 04 02; 372(14):1373-4. PMID: 25830429.
    View in: PubMed
  158. Waldo SW, McCabe JM, O'Brien C, Kennedy KF, Joynt KE, Yeh RW. Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction. J Am Coll Cardiol. 2015 Mar 24; 65(11):1119-26. PMID: 25790884; PMCID: PMC4368858.
  159. Secemsky EA, Matteau A, Yeh RW, Steg PG, Camenzind E, Wijns W, McFadden E, Mauri L. Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials). Am J Cardiol. 2015 Jun 15; 115(12):1678-84. PMID: 25910523.
    View in: PubMed
  160. Yeh RW, Cohen DJ, Mauri L. Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy. Eur Heart J. 2015 May 21; 36(20):1216-8. PMID: 25796054.
    View in: PubMed
  161. Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA. 2015 Mar 17; 313(11):1113-21. PMID: 25781440; PMCID: PMC4481320.
  162. Yeh RW, Kereiakes DJ, Steg PG, Windecker S, Rinaldi MJ, Gershlick AH, Cutlip DE, Cohen DJ, Tanguay JF, Jacobs A, Wiviott SD, Massaro JM, Iancu AC, Mauri L. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. J Am Coll Cardiol. 2015 May 26; 65(20):2211-21. PMID: 25787199; PMCID: PMC4678101.
  163. Yeh RW, Mauri L, Kereiakes DJ. Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected]. J Am Coll Cardiol. 2015 Mar 03; 65(8):787-790. PMID: 25720621; PMCID: PMC4689133.
  164. Yeh RW, Mauri L, Wolf RE, Romm IK, Lovett A, Shahian D, Normand SL. Population trends in rates of coronary revascularization. JAMA Intern Med. 2015 Mar; 175(3):454-6. PMID: 25559059; PMCID: PMC4385321.
  165. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27; 131(4):e29-322. PMID: 25520374.
    View in: PubMed
  166. Kumar A, Matheny ME, Ho KK, Yeh RW, Piemonte TC, Waldman H, Shah PB, Cope R, Normand SL, Donnelly S, Robbins S, Resnic FS. The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):38-46. PMID: 25491915.
    View in: PubMed
  167. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014 Dec 04; 371(23):2155-66. PMID: 25399658; PMCID: PMC4481318.
  168. Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L. Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):96-102. PMID: 25399847; PMCID: PMC4303486.
  169. Elmariah S, Mauri L, Doros G, Galper BZ, O'Neill KE, Steg PG, Kereiakes DJ, Yeh RW. Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis. Lancet. 2015 Feb 28; 385(9970):792-8. PMID: 25467565; PMCID: PMC4386690.
  170. Yeh RW, Drachman DE. Culprit only, multivessel, or staged multivessel intervention in STEMI: new insights or insurmountable methodologic obstacles? Catheter Cardiovasc Interv. 2014 Nov 15; 84(6):923-4. PMID: 25352189.
    View in: PubMed
  171. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2014 Dec 23; 130(25):2295-301. PMID: 25391519; PMCID: PMC4276481.
  172. Garg P, Galper BZ, Cohen DJ, Yeh RW, Mauri L. Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents. Am Heart J. 2015 Feb; 169(2):222-233.e5. PMID: 25641531; PMCID: PMC4407277.
  173. Young MN, Yeh RW. Public reporting and coronary revascularization: risk and benefit. Coron Artery Dis. 2014 Nov; 25(7):619-26. PMID: 25248138.
    View in: PubMed
  174. Wasfy JH, Strom JB, Waldo SW, O'Brien C, Wimmer NJ, Zai AH, Luttrell J, Spertus JA, Kennedy KF, Normand SL, Mauri L, Yeh RW. Clinical preventability of 30-day readmission after percutaneous coronary intervention. J Am Heart Assoc. 2014 Sep 26; 3(5):e001290. PMID: 25261531; PMCID: PMC4323776.
  175. Baron SJ, Yeh RW, Cohen DJ. The challenges of success: maintaining access to high-quality percutaneous coronary intervention in the face of declining procedural volumes. Circulation. 2014 Oct 14; 130(16):1343-5. PMID: 25189216.
    View in: PubMed
  176. Yeh RW, Wimmer NJ. Blood transfusion in myocardial infarction: opening old wounds for comparative-effectiveness research. J Am Coll Cardiol. 2014 Aug 26; 64(8):820-2. PMID: 25145527.
    View in: PubMed
  177. Potter BJ, Yeh RW, Pinto DS. Public reporting of PCI outcomes: for better or for worse. Curr Cardiol Rep. 2014 Jul; 16(7):500. PMID: 24893937.
    View in: PubMed
  178. McCabe JM, Kennedy KF, Yeh RW. Defining unavoidable delays in primary percutaneous coronary intervention: discordance among patients excluded from National Cardiovascular Quality Registries. J Am Heart Assoc. 2014 Jun 25; 3(3):e000944. PMID: 24965027; PMCID: PMC4309035.
  179. Strom JB, Wimmer NJ, Wasfy JH, Kennedy K, Yeh RW. Association between operator procedure volume and patient outcomes in percutaneous coronary intervention: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2014 Jul; 7(4):560-6. PMID: 24939939.
    View in: PubMed
  180. Wimmer NJ, Spertus JA, Kennedy KF, Anderson HV, Curtis JP, Weintraub WS, Singh M, Rumsfeld JS, Masoudi FA, Yeh RW. Clinical prediction model suitable for assessing hospital quality for patients undergoing carotid endarterectomy. J Am Heart Assoc. 2014 Jun 17; 3(3):e000728. PMID: 24938712; PMCID: PMC4309056.
  181. Vardi M, Perez J, Griffin PJ, Burke DA, Yeh RW, Cutlip DE. Usefulness of postmarket studies to evaluate long-term safety of coronary eluting stents (from the ENDEAVOR and PROTECT Programs). Am J Cardiol. 2014 Aug 15; 114(4):528-33. PMID: 24994546.
    View in: PubMed
  182. Czarny MJ, Nathan AS, Yeh RW, Mauri L. Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol. 2014 Aug; 37(8):505-13. PMID: 24797884; PMCID: PMC4140973.
  183. Wimmer NJ, Cohen DJ, Wasfy JH, Rathore SS, Mauri L, Yeh RW. Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable? Am Heart J. 2014 Jul; 168(1):103-9. PMID: 24952866; PMCID: PMC4067602.
  184. Yeh RW, Wimmer NJ. Reply: Bleeding after PCI, vascular access, and falsification endpoints in observational studies. J Am Coll Cardiol. 2014 Jun 17; 63(23):2587-2588. PMID: 24681135.
    View in: PubMed
  185. McNulty EJ, Hung YY, Almers LM, Go AS, Yeh RW. Population trends from 2000-2011 in nuclear myocardial perfusion imaging use. JAMA. 2014 Mar 26; 311(12):1248-9. PMID: 24668108.
    View in: PubMed
  186. Rassi AN, Yeh RW. Cardiovascular event risk after noncardiac surgery. JAMA. 2014 Feb 05; 311(5):525. PMID: 24496540.
    View in: PubMed
  187. Vardi M, Novack V, Pencina MJ, Doros G, Burke DA, Elmariah S, Cutlip DE, Mauri L, Yeh RW. Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies. Catheter Cardiovasc Interv. 2014 May 01; 83(6):975-83. PMID: 23996913.
    View in: PubMed
  188. Katzan IL, Spertus J, Bettger JP, Bravata DM, Reeves MJ, Smith EE, Bushnell C, Higashida RT, Hinchey JA, Holloway RG, Howard G, King RB, Krumholz HM, Lutz BJ, Yeh RW. Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Mar; 45(3):918-44. PMID: 24457296.
    View in: PubMed
  189. Giri J, Kennedy KF, Weinberg I, Hawkins BM, Press MC, Drachman D, McCormick DJ, Aronow HD, White CJ, Rosenfield K, Yeh RW. Comparative effectiveness of commonly used devices for carotid artery stenting: an NCDR Analysis (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2014 Feb; 7(2):171-177. PMID: 24440025.
    View in: PubMed
  190. Wasfy JH, Strom JB, O'Brien C, Zai AH, Luttrell J, Kennedy KF, Spertus JA, Zelevinsky K, Normand SL, Mauri L, Yeh RW. Causes of short-term readmission after percutaneous coronary intervention. Circ Cardiovasc Interv. 2014 Feb; 7(1):97-103. PMID: 24425587.
    View in: PubMed
  191. Hawkins BM, Fitzgerald-McKeon LM, Yeh RW. High-risk percutaneous coronary intervention in the era of public reporting: clinical and ethical considerations in the care of an elderly patient with critical left main disease and shock. Circulation. 2014 Jan 14; 129(2):258-65. PMID: 24421361; PMCID: PMC4004630.
  192. Stefanescu A, Macklin EA, Lin E, Dudzinski DM, Johnson J, Kennedy KF, Jacoby D, DeFaria Yeh D, Lewis GD, Yeh RW, Liberthson R, Lui G, Bhatt AB. Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome. Am J Cardiol. 2014 Mar 01; 113(5):865-70. PMID: 24411285.
    View in: PubMed
  193. Hawkins BM, McCoy LA, Neely ML, Adusumalli S, Messenger JC, Drachman DE, Bass TA, O'Gara PT, Rao SV, Yeh RW. Impact of academic year timing on percutaneous coronary intervention outcomes at training institutions. J Am Coll Cardiol. 2014 Mar 18; 63(10):1025-6. PMID: 24333492.
    View in: PubMed
  194. Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio JJ, Pierce K, Deik A, Gerszten RE, Thadhani R, Rhee EP. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J Am Heart Assoc. 2013 Dec 05; 2(6):e000542. PMID: 24308938; PMCID: PMC3886735.
  195. Chiang A, Gada H, Kodali SK, Lee MS, Jeremias A, Pinto DS, Bangalore S, Yeh RW, Henry TD, Lopez-Cruz G, Mehran R, Kirtane AJ. Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv. 2014 Apr 01; 83(5):721-6. PMID: 24273213.
    View in: PubMed
  196. Yeh RW, Vasaiwala S, Forman DE, Silbaugh TS, Zelevinski K, Lovett A, Normand SL, Mauri L. Instrumental variable analysis to compare effectiveness of stents in the extremely elderly. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):118-24. PMID: 24254887.
    View in: PubMed
  197. McCabe JM, Kennedy KF, Eisenhauer AC, Waldman HM, Mort EA, Pomerantsev E, Resnic FS, Yeh RW. Reporting trends and outcomes in ST-segment-elevation myocardial infarction national hospital quality assessment programs. Circulation. 2014 Jan 14; 129(2):194-202. PMID: 24249721.
    View in: PubMed
  198. Giri J, Yeh RW, Kennedy KF, Hawkins BM, Weinberg I, Weinberg MD, Parikh SA, Garasic J, Jaff MR, White CJ, Rosenfield K. Unprotected carotid artery stenting in modern practice. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):595-602. PMID: 23804411.
    View in: PubMed
  199. Matteau A, Yeh RW, Kereiakes D, Orav EJ, Massaro J, Steg PG, Normand SL, Cutlip DE, Mauri L. Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study). Am J Cardiol. 2014 Apr 01; 113(7):1146-52. PMID: 24332248.
    View in: PubMed
  200. Masoudi FA, Ponirakis A, Yeh RW, Maddox TM, Beachy J, Casale PN, Curtis JP, De Lemos J, Fonarow G, Heidenreich P, Koutras C, Kremers M, Messenger J, Moussa I, Oetgen WJ, Roe MT, Rosenfield K, Shields TP, Spertus JA, Wei J, White C, Young CH, Rumsfeld JS. Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. J Am Coll Cardiol. 2013 Nov 19; 62(21):1931-1947. PMID: 24036027.
    View in: PubMed
  201. Vardi M, Yeh RW, Herzog CA, Winkelmayer WC, Setoguchi S, Charytan DM. Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2213-20. PMID: 23970129; PMCID: PMC3848407.
  202. Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Yeh RW. Comparison of transradial versus transfemoral percutaneous coronary intervention in routine practice: evidence for the importance of "falsification hypotheses" in observational studies of comparative effectiveness. J Am Coll Cardiol. 2013 Dec 03; 62(22):2147-8. PMID: 23954334.
    View in: PubMed
  203. Yonetsu T, Kato K, Uemura S, Kim BK, Jang Y, Kang SJ, Park SJ, Lee S, Kim SJ, Jia H, Vergallo R, Abtahian F, Tian J, Hu S, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Yu B, Kakuta T, Jang IK. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography. Circ Cardiovasc Imaging. 2013 Sep; 6(5):665-73. PMID: 23922003.
    View in: PubMed
  204. Wasfy JH, Rosenfield K, Zelevinsky K, Sakhuja R, Lovett A, Spertus JA, Wimmer NJ, Mauri L, Normand SL, Yeh RW. A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):429-35. PMID: 23819957.
    View in: PubMed
  205. Yeh RW, Drachman DE. Coronary chronic total occlusion in the elderly: demographic inevitability, treatment uncertainty. Catheter Cardiovasc Interv. 2013 Jul 01; 82(1):93-4. PMID: 23788388.
    View in: PubMed
  206. Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Piemonte TC, Pomerantsev E, Ho KK, Robbins SL, Waldman HM, Yeh RW. Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J Am Heart Assoc. 2013 May 24; 2(3):e000174. PMID: 23709565; PMCID: PMC3698780.
  207. Rhee EP, Clish CB, Ghorbani A, Larson MG, Elmariah S, McCabe E, Yang Q, Cheng S, Pierce K, Deik A, Souza AL, Farrell L, Domos C, Yeh RW, Palacios I, Rosenfield K, Vasan RS, Florez JC, Wang TJ, Fox CS, Gerszten RE. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol. 2013 Jul; 24(8):1330-8. PMID: 23687356; PMCID: PMC3736702.
  208. Mauer AC, Baron SJ, Yeh RW, Scott NS. Caesarian dissection: a case of chest pain and dyspnea during delivery. Circulation. 2013 Apr 09; 127(14):1530-5. PMID: 23569120.
    View in: PubMed
  209. Wayangankar SA, Abu-Fadel MS, Aronow HD, Kennedy KF, Gupta R, Yeh RW, Gray WA, Rosenfield K, Hennebry TA. Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR. Circ Cardiovasc Interv. 2013 Apr; 6(2):131-8. PMID: 23532554.
    View in: PubMed
  210. Amin AP, Bachuwar A, Reid KJ, Chhatriwalla AK, Salisbury AC, Yeh RW, Kosiborod M, Wang TY, Alexander KP, Gosch K, Cohen DJ, Spertus JA, Bach RG. Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status. J Am Coll Cardiol. 2013 May 28; 61(21):2130-8. PMID: 23541975; PMCID: PMC4332538.
  211. Zigler CM, Watts K, Yeh RW, Wang Y, Coull BA, Dominici F. Model feedback in Bayesian propensity score estimation. Biometrics. 2013 Mar; 69(1):263-73. PMID: 23379793; PMCID: PMC3622139.
  212. Wimmer NJ, Yeh RW, Cutlip DE, Mauri L. Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke. 2012 Dec; 43(12):3218-24. PMID: 23127975.
    View in: PubMed
  213. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012 Nov; 5(11):1150-8. PMID: 23174639.
    View in: PubMed
  214. Hawkins BM, Kennedy KF, Giri J, Saltzman AJ, Rosenfield K, Drachman DE, White CJ, Spertus JA, Yeh RW. Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE Registry. J Am Coll Cardiol. 2012 Oct 23; 60(17):1617-22. PMID: 22999733.
    View in: PubMed
  215. Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med. 2012 Aug 13; 172(15):1145-52. PMID: 22777536.
    View in: PubMed
  216. Wimmer NJ, Yeh RW. Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention. Trends Cardiovasc Med. 2012 Jan; 22(1):23-8. PMID: 22841840; PMCID: PMC4334450.
  217. Kunz LM, Yeh RW, Normand SL. Comparative effectiveness research: does one size fit all? Stat Med. 2012 Nov 10; 31(25):3062-5; discussion 3066-7. PMID: 22806612.
    View in: PubMed
  218. Rothman RD, Baggish AL, O'Callaghan C, Lowry PA, Bhatt AB, MacRae CA, Yannekis G, Sanborn DM, Mela T, Yeh RW, Palacios I, Vlahakes GJ, Fifer MA. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. Am J Cardiol. 2012 Oct 15; 110(8):1169-74. PMID: 22766229.
    View in: PubMed
  219. Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Uemura S, Yu B, Kakuta T, Jang IK. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012 Oct 01; 110(7):933-9. PMID: 22727183.
    View in: PubMed
  220. Armstrong EJ, Xing L, Zhang J, Zheng Y, Shunk KA, Yeh RW, Farzaneh-Far R, Yu B, Jang IK. Association between leukocyte telomere length and drug-eluting stent strut coverage by optical coherence tomography. J Am Coll Cardiol. 2012 Jun 12; 59(24):2218-9. PMID: 22676944.
    View in: PubMed
  221. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012 Jul; 5(4):433-40. PMID: 22679059.
    View in: PubMed
  222. Shahian DM, Meyer GS, Yeh RW, Fifer MA, Torchiana DF. Percutaneous coronary interventions without on-site cardiac surgical backup. N Engl J Med. 2012 May 10; 366(19):1814-23. PMID: 22571203.
    View in: PubMed
  223. Yeh RW, Rosenfield K, Zelevinsky K, Mauri L, Sakhuja R, Shivapour DM, Lovett A, Weiner BH, Jacobs AK, Normand SL. Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention. Circ Cardiovasc Interv. 2012 Apr; 5(2):227-36. PMID: 22438431.
    View in: PubMed
  224. Yeh RW, Normand SL, Wang Y, Barr CD, Dominici F. Geographic disparities in the incidence and outcomes of hospitalized myocardial infarction: does a rising tide lift all boats? Circ Cardiovasc Qual Outcomes. 2012 Mar 01; 5(2):197-204. PMID: 22354937; PMCID: PMC3310945.
  225. Yeh RW, Mauri L. Choosing methods to minimize confounding in observational studies: do the ends justify the means? Circ Cardiovasc Qual Outcomes. 2011 Nov 01; 4(6):581-3. PMID: 22085982.
    View in: PubMed
  226. Yeh RW, Normand SL, Wolf RE, Jones PG, Ho KK, Cohen DJ, Cutlip DE, Mauri L, Kugelmass AD, Amin AP, Spertus JA. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation. 2011 Oct 04; 124(14):1557-64. PMID: 21900079.
    View in: PubMed
  227. McNulty EJ, Ng W, Spertus JA, Zaroff JG, Yeh RW, Ren XM, Lundstrom RJ. Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies. JACC Cardiovasc Interv. 2011 Sep; 4(9):1020-7. PMID: 21939943.
    View in: PubMed
  228. DeFaria Yeh D, Lonergan KL, Fu D, Yeh RW, Echt DS, Foster E. Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing. Europace. 2011 Dec; 13(12):1760-5. PMID: 21798878.
    View in: PubMed
  229. Yeh RW, Chandra M, McCulloch CE, Go AS. Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med. 2011 Jun 24; 9:78. PMID: 21702899; PMCID: PMC3141543.
  230. Brentjens RJ, Riviere I, Park J, Davilla M, Wang X, Yeh R, Lamanna N, Frattini MG, Sadelain M. Lymphodepletion and tumor burden govern clinical responses in patients with B-cell malignancies treated with autologous, CD19-targeted T cells. J Clin Oncol. 2011 May 20; 29(15_suppl):2534. PMID: 28022329.
    View in: PubMed
  231. Sakhuja R, Yeh RW, Bhatt DL. Anticoagulant agents in acute coronary syndromes. Curr Probl Cardiol. 2011 Apr; 36(4):127-68. PMID: 21586352.
    View in: PubMed
  232. Yeh RW, Kennedy K, Spertus JA, Parikh SA, Sakhuja R, Anderson HV, White CJ, Rosenfield K. Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting. Circulation. 2011 Apr 05; 123(13):1384-90. PMID: 21422383.
    View in: PubMed
  233. Longmore RB, Yeh RW, Kennedy KF, Anderson HV, White CJ, Longmore LS, Rosenfield K, Ho KK, Spertus JA. Clinical referral patterns for carotid artery stenting versus carotid endarterectomy: results from the Carotid Artery Revascularization and Endarterectomy Registry. Circ Cardiovasc Interv. 2011 Feb 01; 4(1):88-94. PMID: 21224465.
    View in: PubMed
  234. Suh WM, Yeh RW, Watkins MT, Palacios IF. Inadvertent femoral endarterectomy: a complication from a suture-based vascular closure device. J Vasc Access. 2011 Jan-Mar; 12(1):71-2. PMID: 21077045.
    View in: PubMed
  235. Yoon JH, Yeh RW, Nam KH, Hoffman WD, Agnihotri AK, Jang IK. Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period. J Thromb Thrombolysis. 2010 Oct; 30(3):276-80. PMID: 20449633.
    View in: PubMed
  236. Yeh RW, Yu PB, Drachman DE. Takotsubo cardiomyopathy complicated by cardiac tamponade: classic hemodynamic findings with a new disease. Circulation. 2010 Sep 21; 122(12):1239-41. PMID: 20855670.
    View in: PubMed
  237. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010 Jun 10; 362(23):2155-65. PMID: 20558366.
    View in: PubMed
  238. Yeh RW, Go AS. Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med. 2010 May 10; 170(9):759-64. PMID: 20458082.
    View in: PubMed
  239. Sakhuja R, Yeh RW, Bhatt DL. Antiplatelet agents in acute coronary syndromes. Curr Probl Cardiol. 2010 Mar; 35(3):123-70. PMID: 20152547.
    View in: PubMed
  240. Yeh DD, Lu JT, Kim A, Yeh RW, Scheinman MM. Calcium-triggered short-coupled polymorphous ventricular tachycardia. Pacing Clin Electrophysiol. 2010 Jan; 33(1):117-22. PMID: 20444143.
    View in: PubMed
  241. Yeh RW, Baron SJ, Healy JL, Pomerantsev E, McNulty IA, Cruz-Gonzalez I, Jang IK. Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes. Catheter Cardiovasc Interv. 2009 Aug 01; 74(2):359-64. PMID: 19213062.
    View in: PubMed
  242. Cruz-Gonzalez I, Sanchez-Ledesma M, Osakabe M, Watanabe H, Baron SJ, Healy JL, Yeh RW, Jang IK. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention? Blood Coagul Fibrinolysis. 2008 Jul; 19(5):401-4. PMID: 18600089.
    View in: PubMed
  243. Baron SJ, Yeh RW, Cruz-Gonzalez I, Healy JL, Pomerantsev E, Garasic J, Drachman D, Rosenfield K, Jang IK. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease. Catheter Cardiovasc Interv. 2008 Jul 01; 72(1):116-20. PMID: 18546237.
    View in: PubMed
  244. Pellegrini CN, Yeh RW, Olgin J, Lee BK. Episodic ventricular pacing with intact atrioventricular nodal function in a DDDR device: what is the rhythm and how can it be prevented? Heart Rhythm. 2008 Jun; 5(6):897-8. PMID: 18534376.
    View in: PubMed
  245. Yeh RW, Wiviott SD, Giugliano RP, Morrow DA, Shui A, Qin J, Scirica B, Bradner JE, Jang IK, Gibson CM, Antman EM. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes. Am J Cardiol. 2007 Dec 15; 100(12):1734-8. PMID: 18082517.
    View in: PubMed
  246. Destito G, Yeh R, Rae CS, Finn MG, Manchester M. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chem Biol. 2007 Oct; 14(10):1152-62. PMID: 17961827; PMCID: PMC2293326.
  247. Cruz-Gonzalez I, Sanchez-Ledesma M, Baron SJ, Healy JL, Watanabe H, Osakabe M, Yeh RW, Jang IK. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome. J Thromb Thrombolysis. 2008 Apr; 25(2):214-8. PMID: 17632689.
    View in: PubMed
  248. Ferencik M, Gregory SA, Butler J, Achenbach S, Yeh RW, Hoffmann U, Inglessis I, Cury RC, Nieman K, McNulty IA, Healy JA, Brady TJ, Semigran MJ, Jang IK. Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography. J Heart Lung Transplant. 2007 May; 26(5):478-84. PMID: 17449417.
    View in: PubMed
  249. Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007 Feb; 83(2):592-7. PMID: 17257993.
    View in: PubMed
  250. Gregory SA, Ferencik M, Achenbach S, Yeh RW, Hoffmann U, Inglessis I, Cury RC, Nieman K, McNulty IA, Laffan JA, Pomerantsev EV, Brady TJ, Semigran MJ, Jang IK. Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. Am J Cardiol. 2006 Oct 01; 98(7):877-84. PMID: 16996866.
    View in: PubMed
  251. Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J. 2006 Aug; 152(2):290.e1-7. PMID: 16875910.
    View in: PubMed
  252. Yeh RW, Everett BM, Foo SY, Dorer DJ, Laposata M, Van Cott EM, Jang IK. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization. Am J Cardiol. 2006 Aug 01; 98(3):419-21. PMID: 16860036.
    View in: PubMed
  253. Yeh RW, Jang IK. Argatroban: update. Am Heart J. 2006 Jun; 151(6):1131-8. PMID: 16781211.
    View in: PubMed
  254. Yeh RW, Gerson LB, Triadafilopoulos G. Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus. Dis Esophagus. 2003; 16(3):193-8. PMID: 14641308.
    View in: PubMed
  255. Zhao KW, Yeh R, Miller AL. Purification and characterization of human lymphoblast N-acetylglucosamine-1-phosphotransferase. Glycobiology. 1992 Apr; 2(2):119-25. PMID: 1318762.
    View in: PubMed
  256. INSELBERG A, VONFOERSTER H, YEH R, CHENG SM. COMPUTATION OF VARIANTS IN CONTINUOUS AND DISCRETE MANIFOLDS. TECHN DOCUM REP AMRL-TDR-63-40. AMRL TR. 1963 May; 1-106. PMID: 14131173.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yeh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (492)
Explore
_
Co-Authors (113)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_